ZA889497B - Vectors and compounds for expression of zymogen forms of human protein c - Google Patents

Vectors and compounds for expression of zymogen forms of human protein c

Info

Publication number
ZA889497B
ZA889497B ZA889497A ZA889497A ZA889497B ZA 889497 B ZA889497 B ZA 889497B ZA 889497 A ZA889497 A ZA 889497A ZA 889497 A ZA889497 A ZA 889497A ZA 889497 B ZA889497 B ZA 889497B
Authority
ZA
South Africa
Prior art keywords
vectors
expression
compounds
human protein
zymogen forms
Prior art date
Application number
ZA889497A
Other languages
English (en)
Inventor
Nils Ulrik Bang
Ulrik Bang Nils
Hartmut Josef Ehrlich
Josef Ehrlich Hartmut
Brian William Grinnell
William Grinnell Brian
Sau-Chi Betty Yan
Betty Yan Sau-Chi
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA889497B publication Critical patent/ZA889497B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
ZA889497A 1987-12-28 1988-12-20 Vectors and compounds for expression of zymogen forms of human protein c ZA889497B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13800987A 1987-12-28 1987-12-28

Publications (1)

Publication Number Publication Date
ZA889497B true ZA889497B (en) 1990-08-29

Family

ID=22480037

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA889497A ZA889497B (en) 1987-12-28 1988-12-20 Vectors and compounds for expression of zymogen forms of human protein c

Country Status (21)

Country Link
EP (1) EP0323149B1 (da)
JP (1) JP2851287B2 (da)
KR (1) KR890010202A (da)
CN (1) CN1035526A (da)
AR (1) AR244804A1 (da)
AT (1) ATE116368T1 (da)
AU (1) AU609919B2 (da)
CA (1) CA1340111C (da)
DE (1) DE3852625T2 (da)
DK (1) DK723488A (da)
ES (1) ES2065341T3 (da)
GR (1) GR3015609T3 (da)
HU (1) HU210863B (da)
IE (1) IE66337B1 (da)
IL (1) IL88758A (da)
MX (1) MX14312A (da)
NZ (1) NZ227434A (da)
PT (1) PT89285B (da)
RU (1) RU2018535C1 (da)
SU (1) SU1739854A3 (da)
ZA (1) ZA889497B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03501921A (ja) * 1987-05-18 1991-05-09 インテグレイテッド・ジェネティクス・インク 改良タンパク質分子、並びにその製造及び活性化方法
US4992373A (en) * 1987-12-04 1991-02-12 Eli Lilly And Company Vectors and compounds for direct expression of activated human protein C
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids
DE69032029T2 (de) * 1989-12-29 1998-08-20 Zymogenetics, Inc., Seattle, Wash. Hybrides protein c
US5358932A (en) * 1989-12-29 1994-10-25 Zymogenetics, Inc. Hybrid protein C
IL97311A0 (en) * 1990-02-23 1992-05-25 Lilly Co Eli Vectors and compounds for expression of glycosylation mutants of human protein c
US5270178A (en) * 1990-02-23 1993-12-14 Eli Lilly And Company Vectors and compounds for expression of zymogen forms of human protein C
MY110664A (en) * 1992-05-21 1999-01-30 Lilly Co Eli Protein c derivatives
US5618714A (en) * 1993-12-15 1997-04-08 Eli Lilly And Company Methods for producing protein C
WO2001036462A2 (en) * 1999-11-19 2001-05-25 Eli Lilly And Company Protein c derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C

Also Published As

Publication number Publication date
AR244804A1 (es) 1993-11-30
CN1035526A (zh) 1989-09-13
AU609919B2 (en) 1991-05-09
CA1340111C (en) 1998-11-03
IL88758A0 (en) 1989-07-31
IL88758A (en) 1994-02-27
PT89285A (pt) 1989-12-29
EP0323149A2 (en) 1989-07-05
HUT50499A (en) 1990-02-28
DK723488D0 (da) 1988-12-27
EP0323149B1 (en) 1994-12-28
ES2065341T3 (es) 1995-02-16
SU1739854A3 (ru) 1992-06-07
RU2018535C1 (ru) 1994-08-30
PT89285B (pt) 1993-08-31
JP2851287B2 (ja) 1999-01-27
KR890010202A (ko) 1989-08-07
DE3852625T2 (de) 1995-05-24
AU2732988A (en) 1989-06-29
ATE116368T1 (de) 1995-01-15
DK723488A (da) 1989-06-29
HU210863B (en) 1995-08-28
JPH022376A (ja) 1990-01-08
NZ227434A (en) 1991-03-26
MX14312A (es) 1994-01-31
GR3015609T3 (en) 1995-06-30
IE883849L (en) 1989-06-28
IE66337B1 (en) 1995-12-27
EP0323149A3 (en) 1990-06-13
DE3852625D1 (de) 1995-02-09

Similar Documents

Publication Publication Date Title
KR970009081B1 (en) Vectors and compounds for direct expression of activated human protein c
EP0443875A3 (en) Vectors and compounds for expression of zymogen forms of human protein c
AR244804A1 (es) Secuencia de dna que codifica una forma zimogena de la proteina c humana, vector de expresion, celulas eucarioticas transformadas y metodo para formas zimogenas de dicha proteina c.
GB8707932D0 (en) Treatment of hair
EP0287028A3 (en) Method of separating activated human protein c
IL78314A0 (en) Expression vectors and methods for the production of recombinant human renin
HU910604D0 (en) Vectors and compounds for expressing glycosyled derivatives of human c protein
GB8510038D0 (en) Treatment of keratinous materials
GB8619830D0 (en) Inhibitor of protein synthesis
GB8707293D0 (en) Preventing inactivation of g proteins
HU911530D0 (en) Vectors and compounds for expression of glycosyled derivatives of human c protein
AU605580C (en) Aerosolization of protein therapeutic agent
PL265099A1 (en) Method of obtaining stable aerosole preparations
IE881525L (en) Preparation of protein
IE871889L (en) Inhibitor of protein synthesis
ZA832587B (en) Preparation of functional human urokinase proteins
GB8719468D0 (en) Radio-labelling of proteins
GB8401299D0 (en) Isolation of protein
PL276132A1 (en) Method of obtaining pigmentous preparations
PL276126A1 (en) Method of obtaining pigementous preparations
PL276125A1 (en) Method of obtaining pigmentous preparations
PL276130A1 (en) Method of obtaining pigmentous preparations
PL276129A1 (en) Method of obtaining pigemnous preparations
PL276127A1 (en) Method of obtaining pigmentous preparations
PL276128A1 (en) Method of obtaining pigmentous preparations